Hyperactive leptin signaling has been implicated in pathogenesis and metastases in gynecological and breast cancers by inducing cell proliferation and reduces cell apoptosis by activating c-myc in cervical cancer [32,33]. This evidence concerns the gene LEP and breast cancer.